Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancer.

Anticancer research - 1 Aug 2012

Szkandera Joanna, Absenger Gudrun, Stotz Michael, Weissmueller Melanie, Winder Thomas, Langsenlehner Tanja, Samonigg Hellmut, Renner Wilfried, Schippinger Walter, Gerger Armin

Abstract excerpt

Recent data suggest that erythropoietin (EPO) plays a substantial role in cancer development and clinical outcome by stimulating cell proliferation, invasion and angiogenesis. A functional polymorphism (rs1617640 G>T) in the promoter region of the EPO gene increases EPO protein expression. In the present study, we investigated the association of EPO rs1617640 G>T with susceptibility and clinical outcome of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms
Share to Cell Transformation, Neoplastic
Share to Erythropoietin
Share to EPO gene
Share to Genetic Predisposition to Disease
Share to Polymorphism, Genetic
Share to Promoter Regions, Genetic
Share to Treatment Outcome

Source

Identifiers

PMID: 22843933

Genes

EPO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancer.PMID 22843933Read ↗

Erythropoietin promoter polymorphism is associated with treatment efficacy and severe hematologic toxicity for platinum-based chemotherapy.Semantic proximity Read ↗

The Erythropoetin rs1617640 Gene Polymorphism Associates with Hemoglobin Levels, Hematocrit and Red Blood Cell Count in Patients with Peripheral Arterial Disease.Semantic proximity Read ↗

Association of erythropoietin gene rs576236 polymorphism and risk of adrenal tumors in a Chinese populationSemantic proximity Read ↗

Functional Ser326Cys polymorphism in the hOGG1 gene is not associated with breast cancer risk.Semantic proximity Read ↗

An association study between hypoxia inducible factor-1alpha (HIF-1α) polymorphisms and osteonecrosis.Semantic proximity Read ↗

Lack of relevance of HIF-1α polymorphisms in breast cancer in a Portuguese population.Semantic proximity Read ↗

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis.Semantic proximity Read ↗

No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk.Semantic proximity Read ↗

HTERT MNS16A polymorphism in breast cancer: a case-control study.Semantic proximity Read ↗

FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.Semantic proximity Read ↗

The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.